Literature DB >> 15889147

Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta.

Julia Kiyan1, Roman Kiyan, Hermann Haller, Inna Dumler.   

Abstract

Urokinase (uPA)-induced signaling in human vascular smooth muscle cells (VSMC) elicits important cellular functional responses, such as cell migration and proliferation. However, how intracellular signaling is linked to glycolipid-anchored uPA receptor (uPAR) is unknown. We provide evidence that uPAR activation by uPA induces its association with platelet-derived growth factor receptor (PDGFR)-beta. The interaction results in PDGF-independent PDGFR-beta activation by phosphorylation of cytoplasmic tyrosine kinase domains and receptor dimerization. Association of the receptors as well as the tyrosine kinase activity of PDGFR-beta are decisive in mediating uPA-induced downstream signaling that regulates VSMC migration and proliferation. These findings provide a molecular basis for mechanisms VSMC use to induce uPAR- and PDGFR-directed signaling. The processes may be relevant to VSMC function and vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889147      PMCID: PMC1142599          DOI: 10.1038/sj.emboj.7600669

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  45 in total

1.  Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells.

Authors:  Stephen M Carlin; Michael Roth; Judith L Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-02-07       Impact factor: 5.464

2.  Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA.

Authors:  E W Raines; S K Dower; R Ross
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

3.  Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery.

Authors:  A W Clowes; M M Clowes; Y P Au; M A Reidy; D Belin
Journal:  Circ Res       Date:  1990-07       Impact factor: 17.367

4.  c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions.

Authors:  Benjamin Hibbert; Yong-Xiang Chen; Edward R O'Brien
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

5.  Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway.

Authors:  Scott T Hollenbeck; Kenji Sakakibara; Peter L Faries; Berhane Workhu; Bo Liu; K Craig Kent
Journal:  J Surg Res       Date:  2004-08       Impact factor: 2.192

6.  Expression and role of PDGF-BB and PDGFR-beta during testis morphogenesis in the mouse embryo.

Authors:  Antonella Puglianiello; Luisa Campagnolo; Donatella Farini; Daria Cipollone; Mario A Russo; Gregorio Siracusa
Journal:  J Cell Sci       Date:  2004-03-01       Impact factor: 5.285

7.  Monocyte-expressed urokinase inhibits vascular smooth muscle cell growth by activating Stat1.

Authors:  Sateesh Kunigal; Angelika Kusch; Natalia Tkachuk; Sergey Tkachuk; Uwe Jerke; Hermann Haller; Inna Dumler
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

8.  Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells.

Authors:  Anna Dimberg; Inger Karlberg; Kenneth Nilsson; Fredrik Oberg
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

9.  LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors.

Authors:  Kousei Tanaga; Hideaki Bujo; Yanjuan Zhu; Tatsuro Kanaki; Satoshi Hirayama; Kazuo Takahashi; Masahiro Inoue; Keiji Mikami; Wolfgang J Schneider; Yasushi Saito
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-27       Impact factor: 8.311

10.  The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.

Authors:  A Estreicher; J Mühlhauser; J L Carpentier; L Orci; J D Vassalli
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539

View more
  31 in total

1.  Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.

Authors:  Fang Wang; W Eric Knabe; Liwei Li; Inha Jo; Timmy Mani; Hartmut Roehm; Kyungsoo Oh; Jing Li; May Khanna; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2012-06-12       Impact factor: 3.641

2.  Structural basis of interaction between urokinase-type plasminogen activator and its receptor.

Authors:  Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew Mazar; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

3.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

4.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

5.  Probing binding and cellular activity of pyrrolidinone and piperidinone small molecules targeting the urokinase receptor.

Authors:  Timmy Mani; Degang Liu; Donghui Zhou; Liwei Li; William Eric Knabe; Fang Wang; Kyungsoo Oh; Samy O Meroueh
Journal:  ChemMedChem       Date:  2013-10-02       Impact factor: 3.466

6.  Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.

Authors:  Ramarao Malla; Sreelatha Gopinath; Kiranmai Alapati; Christopher S Gondi; Meena Gujrati; Dzung H Dinh; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

Review 7.  VEGF-initiated angiogenesis and the uPA/uPAR system.

Authors:  Johannes M Breuss; Pavel Uhrin
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

8.  The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.

Authors:  Minji Jo; Shinako Takimoto; Valerie Montel; Steven L Gonias
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

9.  Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor.

Authors:  Parnian Kalbasi Anaraki; Margret Patecki; Jan Larmann; Sergey Tkachuk; Kerstin Jurk; Hermann Haller; Gregor Theilmeier; Inna Dumler
Journal:  Stem Cells Dev       Date:  2013-12-11       Impact factor: 3.272

10.  Stat1 nuclear translocation by nucleolin upon monocyte differentiation.

Authors:  Uwe Jerke; Sergey Tkachuk; Julia Kiyan; Victoria Stepanova; Angelika Kusch; Michael Hinz; Rainer Dietz; Hermann Haller; Bianca Fuhrman; Inna Dumler
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.